APA (7th ed.) Citation

Bachelot, T., & Schneeweiss, A. (2019). Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). Annals of oncology, 30(5), . https://doi.org/10.1093/annonc/mdz061

Chicago Style (17th ed.) Citation

Bachelot, Thomas, and Andreas Schneeweiss. "Preliminary Safety and Efficacy of First-line Pertuzumab Combined with Trastuzumab and Taxane Therapy for HER2-positive Locally Recurrent or Metastatic Breast Cancer (PERUSE)." Annals of Oncology 30, no. 5 (2019). https://doi.org/10.1093/annonc/mdz061.

MLA (9th ed.) Citation

Bachelot, Thomas, and Andreas Schneeweiss. "Preliminary Safety and Efficacy of First-line Pertuzumab Combined with Trastuzumab and Taxane Therapy for HER2-positive Locally Recurrent or Metastatic Breast Cancer (PERUSE)." Annals of Oncology, vol. 30, no. 5, 2019, https://doi.org/10.1093/annonc/mdz061.